Franziska Michor - Nov 20, 2024 Form 3 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
Jonathan D. Golightly, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Nov 20, 2024
Transactions value $
$0
Form type
3
Date filed
11/22/2024, 06:25 PM

No securities are beneficially owned.